2010 CABA Annual Conference
“Biomedical Today: East Meets West”
生物医药行业前景展望:科技创新与全球化带来的机遇和挑战
Time: Saturday, April 10, 2010 (8:00 AM to 10:00 PM)
Location: MIT Faculty Club, 50 Memorial Drive, Bldg E52, 6th Floor, Cambridge, MA
~~Invited speakers and panelists of US and China biopharmaceutical executives, entrepreneurs, academic professors etc. focusing on topics of “Biomedical Innovation and Asia-Pacific/China Perspectives”.
~~The conference will also include vendor exhibition, career fair and networking reception, followed by dinner reception with keynote speeches. Great networking and career development opportunities.
ADMISSION: CABA members: FREE; Non-members: $20;
Dinner reception: $40 ($30 online pre-registration before April 4, limited tickets available)
美中生物医药协会 (CABA) 将于四月十日(周六)早上八点至晚上十点,在麻省理工学院教师俱乐部 (MIT Faculty Club) 举办2010年会。本次大会的主题为“生物医药行业前景展望: 科技创新与全球化带来的机遇和挑战”。大会邀请了Pfizer,Merck, Novartis,GSK,Shire, Genzyme, Vertex等制药及生物技术公司的资深领袖和Tufts大学, GIBH CAS的知名学者与大家分享医药科技的最新进展;大会并有Sundia,Medicilon,Chempartner,BioDuro,Genscript, Viva, Fountain等CRO公司的行业领袖, 中国领军医药企业和高科技园区的主管与大家共同探讨制药行业全球化为我们带来的前所未有的机遇与挑战。会议还将包括商家展示,就业招聘,交流酒会, 及招待晚宴等。欢迎广大CABA会员,生物医药领域的学生学者, 以及工业界的同仁届时参加,不要错过这一年度行业盛会。
Conference Program Draft*
8:00 AM – 8:30 AM Registration
Opening Keynote -- BIOMEDICAL TODAY: Global Biopharmaceutical R&D
Conference Chair: Dr. Chaoyang Dai
8:40 AM – 9:10AM Prof. Ken Kaitin, Director, Center for Study of Drug Development, Tufts University
“Innovation at a Crossroad: Global Perspectives on Biopharmaceutical R&D”
Session 1 -- CHINA PERSPECTIVES: Innovative Drug R&D and Contract Research
Chair: Dr. Qinglin Che
9:10AM – 9:25AM Dr. Jim Zhang, CEO, JZ Med
“Innovative Drug R&D in China: Overview & Perspectives”
9:25 AM – 9:40 AM Dr. Brian Manning, Director, Genscript
“The Advance of Integrated Biologics CRO Services in China”
9:40 AM – 9:55 AM Dr. Derek Ren, VP, Viva Biotech Inc.
“Drug Discovery with FBDD, SBDD and Target Validation”
9:55AM – 10:10 AM Dr. Joanne Jiang, VP, Fountain Medical Development Ltd
“Clinical Study in China - the New Link of the Drug Development Value Chain”
10:10 AM – 10:30 AM Coffee Break and Exhibition
Session 2 -- INTEGRATED R&D SERVICES: Trends and New Development
Chair: Dr. Zhiyong Yang
10:30 AM – 10:40AM Dr. Charles Huang, VP, Sundia MediTech
“Drug Discovery R&D: China Opportunity - From a Chinese CRO Perspectives”
10:40 AM – 10:50AM Dr. T. J. Deng, VP, BioDuro
“A new approach and partnership to tackle productivity issues in drug discovery and development”
10:50 AM – 11:00 AM Dr. Chunlin Chen, CEO, Medicilon
“Integrated Drug R&D Services: A Maturing Trend and Proven Track Records”
11:00 AM – 11:10 AM Dr. Yajun Xu, SVP, ChemPartner
“Partnering with ChemPartner: Integrated R&D Service Provider”
11:10 AM – 11:30 AM Panel Q&A Drs. Charles Huang, T.J. Deng, Chunlin Chen, Yajun Xu
Session 3 -- CHINA BIOMEDICAL PARKS & ENTERPRISES: Opportunities for Overseas Entrepreneurs
Chair: Dr. Sue Ma
11:30 AM – 11:40 AM Mr. Feng Pan, Director, Wuxi Guanlin High-Tech Park
11:40 AM – 11:50 AM Mr. Charles Ye, Taizhou China Medical City
11:50 AM – 12:00 PM Mr. Yueming Wang, Deputy General Manager, Beijing Tide Pharmaceutical Co. Ltd.
12:00 PM – 1:00 PM Lunch, Career Fair, and Exhibition
Session 4 -- LEADING THE WAY: Innovation as Driving Force to Energize Drug Industry
Chair: Dr. Zhihong Chen
1:00 PM – 1:30 PM Prof. Duanqing Pei, President, Guangzhou Institute of Biomedicine and Health (GIBH), Chinese Academy of Sciences
“Stem Cell Pluripotency and its Application in Disease Modeling”
1:30 PM – 2:00 PM Dr. Youssef Bennani, VP, Vertex Pharmaceuticals
“Natural Product-Inspired Drug Discovery”
2:00 PM – 2:30 PM Dr. William Shakespeare, VP, Drug Discovery, Ariad Pharmaceuticals
“Discovery of AP24534, a pan-Inhibitor of BCR-ABL Including the T315I Gatekeeper Mutation for Chronic Myeloid Leukemia”
2:30 PM – 3:00 PM Dr. Matt Clark, Director, GlaxoSmithKline, Molecular Discovery Research Boston
“Hit Generation by Selection of DNA-Encoded Small Molecule Libraries”
3:00 PM – 3:20 PM Coffee Break and Exhibition
Session 5 -- BROADEN THE HORIZON: Biomedical R&D Partnership in Asia-Pacific/China
Chair: Dr. Yihan Wang
3:20 PM – 3:50 PM Dr. Tom Evans, VP, Novartis China
“Reality of Doing Translational Research in China”
3:50 PM – 4:20 PM Dr. Jim Burns, SVP, Head of Drug & Biomaterial R&D, Genzyme Pharmaceuticals
“R&D Partnerships and Innovation”
4:20 PM – 5:10 PM Panel Forum:
Dr. Reid Leonard, Executive Director, Merck Co.
Dr. Gangfeng Xu, AVP, Pfizer Inc.
Dr. Ping Tse, Chairman, Sino Biopharmaceutical Co. Ltd.
5:10 PM – 5:20 PM Closing Remarks
Dr. Zhao-Kui Wan, President, CABA
“CABA 2009-2010”
5:20 PM – 6:20 PM Cocktail Social Hour, Career Fair, and Exhibition
Dinner Reception -- EAST MEETS WEST: Building up Global Biopharmaceutical R&D Strategies
Chairs: Drs. Chaoyang Dai, Zhao-Kui Wan
6:20 PM – 6:30 PM Wuxi Guanlin Night
6:30 PM – 7:30 PM Dinner
7:30 PM – 8:15 PM Dr. Whaijen Soo, SVP, R&D, Shire Human Genetic Therapies
“Strategic Planning for China Entry: Perspectives from a Full-fledged Global Biopharmaceutical Company”
8:15 PM – 9:00 PM Dr. Suvit Thaisrivongs, VP, Pfizer Inc.
“Making Medicine that Matters: a Fragment-Based Drug Discovery Paradigm”
9:00 PM – 10:00 PM Closing and Networking
For program update & online registration, please check CABA website: www.cabaweb.org.
There are also opportunities to meet 1-on-1 with one of the meeting participants Beijing Sino Pharmaceuticals, Co. on Sunday(April 11). Please use the attached feedback form to sign-up.
Driving direction and parking information:
http://web.mit.edu/facultyclub/about/directions.html
Please use MIT E51 Lot and Hayward Lot for parking; Parking on weekends is free.
Please use the membership application form for on-line registration with "Annual meeting" option selected.
*Program is subject to change without prior notice